Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Sep;14(3):459–461. doi: 10.1111/j.1365-2125.1982.tb02010.x

Alteration of plasma prednisolone levels by indomethacin and naproxen.

S A Rae, I A Williams, J English, E M Baylis
PMCID: PMC1427625  PMID: 7126420

Abstract

Eleven patients with stable rheumatoid disease (RD) who were receiving regular corticosteroid therapy (CS) were investigated to discover the effect on plasma prednisolone levels of additional therapy with the non-steroidal anti-inflammatory (NSAI) drugs, indomethacin and naproxen. There was a highly significant (P less than 0.001) increase in free prednisolone levels after concurrent therapy with either indomethacin or naproxen for 2 weeks. Total prednisolone levels were unchanged. These results could provide an explanation for clinical reports that these two NSAI drugs possess a steroid-sparing effect.

Full text

PDF
459

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Badia Flores J. J., Valdez Rojas S. Naproxen: corticosteroid-sparing effect in rheumatoid arthritis. J Clin Pharmacol. 1975 Apr;15(4 Pt 2):373–377. doi: 10.1002/j.1552-4604.1975.tb01467.x. [DOI] [PubMed] [Google Scholar]
  2. Brodie B. B. Displacement of one drug by another from carrier or receptor sites. Proc R Soc Med. 1965 Nov;58(11 Pt 2):946–955. [PMC free article] [PubMed] [Google Scholar]
  3. Elliott P. R., Powell-Tuck J., Gillespie P. E., Laidlow J. M., Lennard-Jones J. E., English J., Chakraborty J., Marks V. Prednisolone absorption in acute colitis. Gut. 1980 Jan;21(1):49–51. doi: 10.1136/gut.21.1.49. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Henderson R. G., Wheatley T., English J., Chakraborty J., Marks V. Variation in plasma prednisolone concentrations in renal transplant recipients given enteric-coated prednisolone. Br Med J. 1979 Jun 9;1(6177):1534–1536. doi: 10.1136/bmj.1.6177.1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Koch-Weser J. Drug therapy. Serum drug concentrations as therapeutic guides. N Engl J Med. 1972 Aug 3;287(5):227–231. doi: 10.1056/NEJM197208032870505. [DOI] [PubMed] [Google Scholar]
  6. Lewis G. P., Jusko W. J., Graves L., Burke C. W. Prednisone side-effects and serum-protein levels. A collaborative study. Lancet. 1971 Oct 9;2(7728):778–780. doi: 10.1016/s0140-6736(71)92738-3. [DOI] [PubMed] [Google Scholar]
  7. Mathies H. Steroideinsparung durch Aaproxen. Arzneimittelforschung. 1975 Feb;25(2A):318–321. [PubMed] [Google Scholar]
  8. Morkel G. F. Therapeutic value of indomethacin. (A review and clinical study). Curr Ther Res Clin Exp. 1966 Apr;8(4):179–186. [PubMed] [Google Scholar]
  9. Rothermich N. O. An extended study of indomethacin. II. Clinical therapy. JAMA. 1966 Mar 28;195(13):1102–1106. [PubMed] [Google Scholar]
  10. Stenlake J. B., Williams W. D., Davidson A. G., Downie W., Whaley K. The effect of anti-inflammatory drugs on the protein-binding of 11-hydroxysteroids in human plasma in vitro. J Pharm Pharmacol. 1969 Jul;21(7):451–459. doi: 10.1111/j.2042-7158.1969.tb08286.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES